AzTrials
AzTrials

BEHAVIOR CHANGE-BASED PHYSICAL ACTIVITY INTERVENTION IN PAD PATIENTS AFTER ENDOVASCULAR REVASCULARIZATIONNCT07328646

BEHAVIOR CHANGE INTERVENTION AFTER ENDOVASCULAR REVASCULARIZATION IN PAD

A study testing Behavior Change-Based Physical Activity Program, Supervised Exercise Program and Combined Behavior Change and Exercise Program in people with BEHAVIOR CHANGE-BASED PHYSICAL ACTIVITY INTERVENTION IN PAD PATIENTS AFTER ENDOVASCULAR REVASCULARIZATION, run by Muğla Sıtkı Koçman University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study titled "Investigation of the Effect of a Behavior Change-Based Physical Activity Program in Patients with Peripheral Artery Disease Who Have Undergone Endovascular Revascularization" will be conducted by Specialist Physiotherapist Ayşe ADIGÜZEL BAYAR. Read more about this study

Who is it for?
Ages 50 to 80 years
What is being tested?
Behavior Change-Based Physical Activity Program, Supervised Exercise Program and Combined Behavior Change and Exercise Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteTurkey (Türkiye)
Study dates
29 Jun 2024to 15 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male and female participants
  • Aged between 50 and 80 years
  • Able to read, understand, and write Turkish
  • Scheduled to undergo endovascular revascularization for peripheral artery disease

Who cannot join

  • Positive exercise stress test result
  • Presence of cognitive or intellectual impairment
  • Presence of musculoskeletal or neurological conditions that may interfere with physical activity performance or outcome assessment
  • Presence of unstable chronic disease

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Aydın Özel Medinova Hastanesi

    Efeler, Aydın, 09100

Other trials in Turkey (Türkiye)

About this study

Official title: EFFECTIVENESS OF A BEHAVIOR CHANGE INTERVENTION AIMED AT INCREASING PHYSICAL ACTIVITY IN PATIENTS WITH PERIPHERAL ARTERY DISEASE UNDERGOING ENDOVASCULAR REVASCULARIZATION

The study titled "Investigation of the Effect of a Behavior Change-Based Physical Activity Program in Patients with Peripheral Artery Disease Who Have Undergone Endovascular Revascularization" will be conducted by Specialist Physiotherapist Ayşe ADIGÜZEL BAYAR. The study is designed to investigate the effects of a structured physical activity program planned using behavior change techniques after endovascular revascularization on walking capacity, physical function, physical activity level and quality of life in patients with peripheral artery disease.

Being tested
Behavior Change-Based Physical Activity Program, Supervised Exercise Program, Combined Behavior Change and Exercise Program
Keywords
Peripheral Artery Disease, Endovascular Revascularization, Physical Activity, Exercise Therapy, Behavior Change, Walking Capacity, Physical Function, Sedentary Behavior, Quality of Life
Medical subject headings
Peripheral Arterial Disease, Motor Activity, Sedentary Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavior Change-Based Physical Activity ProgramBehavioural

    The program will include behavior change techniques such as goal setting, self-monitoring, action planning, motivational support, and education to promote physical activity and reduce sedentary time.

  • Supervised Exercise ProgramOther

    The supervised exercise program will consist of structured exercise sessions aimed at improving walking capacity and physical function.

  • Combined Behavior Change and Exercise ProgramOther

    This intervention integrates behavior change techniques with supervised exercise to enhance physical activity adherence, walking capacity, physical function, and quality of life.

Study groups in NCT07328646
Study groupRoleWhat they receive
Behavior Change Intervention GroupExperimentalParticipants in this arm will receive a structured behavior change-based physical activity intervention following endovascular revascularization.
Receives: Behavioral: Behavior Change-Based Physical Activity Program
Supervised Exercise GroupActive comparatorParticipants in this arm will receive a supervised exercise program following endovascular revascularization, without a structured behavior change component.
Receives: Other: Combined Behavior Change and Exercise Program
Combined Intervention GroupExperimentalParticipants in this arm will receive a combined intervention including both a behavior change-based.
Receives: Other: Supervised Exercise Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in self-reported physical activity level (IPAQ total score)

    Self-reported physical activity level will be assessed using the International Physical Activity Questionnaire (IPAQ). The primary outcome is the change in total physical activity level, expressed as MET-minutes per week, from baseline.

    Measured: Baseline, 6 weeks, 12 weeks

Secondary outcomes (4)
  1. Change in walking capacity (6-Minute Walk Test distance)

    Walking capacity will be assessed using the 6-Minute Walk Test. The primary endpoint is the change in 6MWT distance (meters) from baseline.

    Measured: Baseline, 6 weeks, 12 weeks

  2. Change in physical function (SPPB total score)

    Physical function will be evaluated using the Short Physical Performance Battery (SPPB). The outcome is the change in SPPB total score from baseline.

    Measured: Baseline, 6 weeks, 12 weeks

  3. Change in walking impairment (WIQ total score)

    Walking impairment will be evaluated using the Walking Impairment Questionnaire (WIQ). The outcome is change in WIQ total score from baseline.

    Measured: Baseline, 6 weeks, 12 weeks

  4. Change in quality of life (SF-12 PCS and MCS)

    Quality of life will be assessed using the 12-Item Short Form Health Survey (SF-12). Outcomes include changes in Physical Component Summary (PCS) and Mental Component Summary (MCS) scores.

    Measured: Baseline, 6 weeks, 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2026
  2. Study start29 Jun 2024
  3. Primary completion15 Dec 2025
  4. Study completion15 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07328646
Sponsor's protocol ID
Phd Thesis
Status last verified
Sep 2026
First submitted
27 Dec 2025
Last updated
28 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Individual participant data will not be shared due to ethical and privacy considerations, as well as the absence of explicit participant consent for data sharing. The study involves a relatively small sample size, which may increase the risk of participant re-identification. Data will be reported only in aggregate form in scientific publications.

Publications

  • Gardner AW, Montgomery PS, Wang M, Shen B. Minimal clinically important differences in daily physical activity outcomes following supervised and home-based exercise in peripheral artery disease. Vasc Med. 2022 Apr;27(2):142-149. doi: 10.1177/1358863X211072913. Epub 2022 Feb 15.

    PubMed 35164605

Questions about this trial

What is this clinical trial studying?

A study testing Behavior Change-Based Physical Activity Program, Supervised Exercise Program and Combined Behavior Change and Exercise Program in people with BEHAVIOR CHANGE-BASED PHYSICAL ACTIVITY INTERVENTION IN PAD PATIENTS AFTER ENDOVASCULAR REVASCULARIZATION, run by Muğla Sıtkı Koçman University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in self-reported physical activity level (IPAQ total score) (time frame: Baseline, 6 weeks, 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07328646, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in